"beta-Lactamases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins.
Descriptor ID |
D001618
|
MeSH Number(s) |
D08.811.277.087.180
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "beta-Lactamases".
Below are MeSH descriptors whose meaning is more specific than "beta-Lactamases".
This graph shows the total number of publications written about "beta-Lactamases" by people in this website by year, and whether "beta-Lactamases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
2004 | 1 | 0 | 1 |
2006 | 4 | 0 | 4 |
2007 | 2 | 3 | 5 |
2008 | 1 | 1 | 2 |
2009 | 3 | 0 | 3 |
2011 | 2 | 1 | 3 |
2012 | 4 | 2 | 6 |
2013 | 5 | 0 | 5 |
2014 | 2 | 1 | 3 |
2015 | 2 | 2 | 4 |
2016 | 7 | 5 | 12 |
2017 | 116 | 66 | 182 |
2018 | 82 | 68 | 150 |
2019 | 27 | 31 | 58 |
2020 | 2 | 4 | 6 |
2021 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "beta-Lactamases" by people in Profiles.
-
Rapid spread of critical priority carbapenemase-producing pathogens in companion animals: a One Health challenge for a post-pandemic world. J Antimicrob Chemother. 2021 08 12; 76(9):2225-2229.
-
Carbapenemase-producing Enterobacterales infections in COVID-19 patients. Infect Dis (Lond). 2022 Jan; 54(1):36-45.
-
Outbreak of NDM-1-producing Klebsiella pneumoniae in the intensive care unit during the COVID-19 pandemic: Another nightmare. Am J Infect Control. 2021 10; 49(10):1324-1326.
-
Trends in fecal carriage of carbapenemase-producing Enterobacterales in children before and after the implementation of international travel restrictions in response to COVID-19. Travel Med Infect Dis. 2021 Sep-Oct; 43:102120.
-
Successful Treatment of Klebsiella pneumoniae NDM Sepsis and Intestinal Decolonization with Ceftazidime/Avibactam Plus Aztreonam Combination in a Patient with TTP Complicated by SARSCoV-2 Nosocomial Infection. Medicina (Kaunas). 2021 Apr 28; 57(5).
-
Daily inpatient ertapenem therapy can be an alternative to hospitalization for the treatment of complicated urinary tract infections during the COVID-19 pandemic. Int J Clin Pract. 2021 Jul; 75(7):e14230.
-
Engineered Ultra-High Affinity Synthetic Antibodies for SARS-CoV-2 Neutralization and Detection. J Mol Biol. 2021 05 14; 433(10):166956.
-
Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital. J Antimicrob Chemother. 2021 01 19; 76(2):380-384.
-
A multidrug-resistant Klebsiella pneumoniae outbreak in a Peruvian hospital: Another threat from the COVID-19 pandemic. Infect Control Hosp Epidemiol. 2022 02; 43(2):267-268.
-
Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? J Hosp Infect. 2021 03; 109:29-31.